Burt Wealth Advisors’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-402
Closed 441
2019
Q4
$0 Buy
+402
New +$309 ﹤0.01% 357

Burt Wealth Advisors's GCVRZ Position: Q1 2020 in Review

Burt Wealth Advisors sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 402 shares.

Burt Wealth Advisors first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $0 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Burt Wealth Advisors reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Burt Wealth Advisors sold 402 Sanofi Contingent Value Rights shares in Q1 2020.
  • Burt Wealth Advisors first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • Burt Wealth Advisors's Sanofi Contingent Value Rights position peaked at $0 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Burt Wealth Advisors's 13F filing for Q1 2020, filed 29 Apr 2020.